First Real-World Evidence of Sparsentan Efficacy in Patients with IgA Nephropathy Treated with SGLT2 Inhibitors

Authors: Moritz Schanz, Severin Schricker, Andrea Schwab, Joerg Latus

Published: 2024-10-28

DOI: 10.1681/asn.2024tg9t6qtt

Keywords: No keywords found.

Abstract:
No abstract found.

Source: